Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
30 hedge funds and large institutions have $5.39M invested in Nemaura Medical, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
31% more call options, than puts
Call options by funds: $17K | Put options by funds: $13K
20% more funds holding
Funds holding: 25 → 30 (+5)
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
29% less capital invested
Capital invested by funds: $7.58M → $5.39M (-$2.19M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.58M |
| 2 |
AC
Armistice Capital
New York
|
+$519K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$141K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$97.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$31.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$209K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$135K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$52.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$21K |
| 5 |
Morgan Stanley
New York
|
-$8.33K |
NMRD Hedge Fund Activity: Q3 2020 in Review
30 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q3 2020, worth a combined $5.39M — down 29% from $7.58M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NMRD positions and 2 closed out — a net gain of 5 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $3.58M. The largest seller was Goldman Sachs, exiting entirely with an estimated $209K sold.
- 30 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q3 2020, up from 25 in Q2 2020.
- Funds reported $5.39M of Nemaura Medical, Inc. Common Stock stock for Q3 2020, down 29% quarter-over-quarter.
- 7 funds opened new Nemaura Medical, Inc. Common Stock positions in Q3 2020 and 2 closed out, a net change of +5 holders.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q3 2020 was Sabby Management, an estimated $3.58M added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q3 2020 was Goldman Sachs, an estimated $209K sold.
Based on aggregated 13F filings for Q3 2020.